Login

Experience the Drillmore difference| Babak Bemani , Chief Executive Officer at Drillmore 00:10:00

Share On Facebook Share On Twitter

Babak Bemani is a CEO & Founder of Bit Azin and Drillmore Canada

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Empowering Investors: UTI's Initiative with Moneycontrol for Financial Literacy | Imtaiyazur Rahman , CEO , UTI Asset Management.
00:10:00
Replay: Gibson Dunn Webinar | The Lawyer Portal | Barbara L. Becker - Chair & Managing Partner of gibson dunn
00:10:00
Fortress Energy's Ambitious Hydrogen Initiative: Leading the Charge Towards Zero Emissions |Wes Edens, Co-Founder, Fortress Investment.
00:10:00
Closing international deals, analyst reports, stock price targets, & more | Andre Larente, CEO, Diagnos IncADK:CVE
00:10:00
Ashan Willy is the CEO at New Relic, a company specializing in observability and monitoring solutions for modern software teams.
00:10:00
"Inside Rathbones: Ian Dembinski on Client Relationships and Wealth Management" | Ian Dembinski - Head of Client Development at Rathbones
00:10:00
Dr. Bret Weinstein shares insights on "The Diary Of A CEO" podcast, while Peter Kaufman discusses M&A strategies in his Gordian Group LLC interview on M&A TV.
00:10:00
Orvana Minerals Update on Taos Project in Argentina
00:10:00
Eleco's Interim CEO Jonathan Hunter Highlights Resilient H1 Results and Future Opportunities in €10 Trillion Construction Industry | Jonathan Hunter , CEO of elecosoft plc
00:10:00
Tim Sime Discusses MFE Inspection Solutions' Innovations and Industry Trends
00:10:00
French energy company discusses gas recovery projects in France and abroad, emphasizing carbon footprint reduction | Julien Moulin, CEO, La Francaise de l Energie SA.
00:10:00
Managing Market Shocks: Nahid Jetha on Portfolio Tail Risk Strategies | CEO, QTS Capital Management LLC

© 2017 - Neuhu+